Direct estimation of the mean outcome on treatment when treatment assignment and discontinuation compete
治疗分配与终止相竞争时治疗下平均结局的直接估计AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要明确研究动态治疗政策下的因果估计目标,并比较直接估计与逆加权估计方法。
治疗分配与终止相竞争时治疗下平均结局的直接估计AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Several authors have investigated the challenges of statistical analyses and inference in the presence of early treatment termination, including a loss of efficiency in randomized controlled trials and a connection to dynamic regimes in observational studies. Popular estimation strategies for causal estimands in dynamic regimes lend themselves to studies where treatment is assigned at a finite number of points and the extension to continuous treatment assignment is nontrivial. We re-examine this from a different perspective and propose a new estimator for the mean outcome of a target treatment length policy that does not involve a treatment model. Because this strategy avoids modelling the treatment assignment mechanism, the estimator works for both discrete and continuous treatment length data and eschews bias and imprecision that arise as a result of coarsening continuous time data into intervals. We show how the competition of treatment length assignment and terminating event lead to a competing risks problem. We exemplify the direct estimator through numerical studies and the analysis of two real datasets. When all modelling assumptions for both the direct and inverse weighted estimators are correct, our simulation studies suggest that the direct estimator is more precise.